Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040

Simple Summary Asbestos consumption figures could be used to construct epidemiological models to forecast the pleural mesothelioma mortality, although they are not frequently taken into consideration in this kind of analysis. Our purpose is to predict the future burden of pleural mesothelioma deaths in Italy until 2039 and to describe the exposure–response curve considering time lasted from the exposure start. Our results could be of interest to plan future needs of the Italian health system and to provide evidence on the consequences of asbestos exposures useful for countries in which this material is, at present, still used for productive activities. Abstract Statistical models used to forecast malignant pleural mesothelioma (MPM) trends often do not take into account historical asbestos consumption, possibly resulting in less accurate predictions of the future MPM death toll. We used the distributed lag non-linear model (DLNM) approach to predict future MPM cases in Italy until 2040, based on past asbestos consumption figures. Analyses were conducted using data on male MPM deaths (1970–2014) and annual asbestos consumption using data on domestic production, importation, and exportation. According to our model, the peak of MPM deaths is expected to occur in 2021 (1122 expected cases), with a subsequent decrease in mortality (344 MPM deaths in 2039). The exposure–response curve shows that relative risk (RR) of MPM increased almost linearly for lower levels of exposure but flattened at higher levels. The lag-specific RR grew until 30 years since exposure and decreased thereafter, suggesting that the most relevant contributions to the risk come from exposures which occurred 20–40 years before death. Our results show that the Italian MPM epidemic is approaching its peak and underline that the association between temporal trends of MPM and time since exposure to asbestos is not monotonic, suggesting a lesser role of remote exposures in the development of MPM than previously assumed.

[1]  G. Tortora,et al.  Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma , 2021, Journal of clinical medicine.

[2]  S. Gray Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma , 2021, BMC Pulmonary Medicine.

[3]  M. Metintaş,et al.  Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study , 2021, Cancers.

[4]  D. Consonni,et al.  Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040 , 2020, International journal of environmental research and public health.

[5]  P. Girardi,et al.  Italian pool of asbestos workers cohorts: asbestos related mortality by industrial sector and cumulative exposure. , 2020, Annali dell'Istituto superiore di sanita.

[6]  S. Silvestri,et al.  [Pandemics and asbestos: for a post-pandemic healthier life]. , 2020, Epidemiologia & Prevenzione.

[7]  E. Taioli,et al.  Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use , 2020, Translational lung cancer research.

[8]  D. Consonni,et al.  Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use , 2020, International journal of environmental research and public health.

[9]  P. Girardi,et al.  Role of asbestos clearance in explaining long-term risk of pleural and peritoneal cancer: a pooled analysis of cohort studies , 2019, Occupational and Environmental Medicine.

[10]  Hongbing Sun North‐south gradient of mesothelioma and asbestos consumption‐production in the United States‐Progresses since the 1st asbestos partial ban in 1973 , 2019, American journal of industrial medicine.

[11]  Jung-Der Wang,et al.  Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[12]  Mohammad Hosein Farzaei,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[13]  J. Takala,et al.  Global Asbestos Disaster , 2018, International journal of environmental research and public health.

[14]  P. Girardi,et al.  The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure , 2017, Occupational and Environmental Medicine.

[15]  F. Colonna,et al.  Economic impact of malignant mesothelioma in Italy: an estimate of the public and social costs. , 2017, La Medicina del lavoro.

[16]  Luís Torgo,et al.  A Comparative Study of Performance Estimation Methods for Time Series Forecasting , 2017, 2017 IEEE International Conference on Data Science and Advanced Analytics (DSAA).

[17]  M. Yokoo,et al.  Estimation of the global burden of mesothelioma deaths from incomplete national mortality data , 2017, Occupational and Environmental Medicine.

[18]  P. Girardi,et al.  Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure , 2017, Occupational and Environmental Medicine.

[19]  P. Demers,et al.  The economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure , 2017, Occupational and Environmental Medicine.

[20]  J. Leigh,et al.  Malignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trends , 2016, Journal of toxicology and environmental health. Part B, Critical reviews.

[21]  Sander Greenland,et al.  Outcome modelling strategies in epidemiology: traditional methods and basic alternatives , 2016, International journal of epidemiology.

[22]  A. Marinaccio,et al.  [Pleural mesothelioma mortality in Italy: time series reconstruction (1970-2009) and comparison with incidence (2003-2008)]. , 2016, Epidemiologia e prevenzione.

[23]  V Torri,et al.  Malignant Pleural Mesothelioma : State of the art and recommendations , 2016 .

[24]  M. Bussacos,et al.  The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil. , 2015, Cancer epidemiology.

[25]  Antonio Gasparrini,et al.  Modeling exposure–lag–response associations with distributed lag non-linear models , 2013, Statistics in medicine.

[26]  P. Fernández-Navarro,et al.  Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020 , 2013, BMC Cancer.

[27]  Eun‐Kee Park,et al.  Potential years of life lost (PYLL) caused by asbestos-related diseases in the world. , 2013, American journal of industrial medicine.

[28]  S. Silvestri Managing Asbestos in Italy: Twenty Years after the Ban , 2013, New solutions : a journal of environmental and occupational health policy : NS.

[29]  C. Furlan,et al.  Pleural mesothelioma: forecasts of the death toll in the area of Casale Monferrato, Italy , 2012, Statistics in medicine.

[30]  R. Tumino,et al.  Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register , 2012, International journal of cancer.

[31]  Eun‐Kee Park,et al.  Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. , 2011, Bulletin of the World Health Organization.

[32]  A. Darnton,et al.  Projection of mesothelioma mortality in Britain using Bayesian methods , 2010, British Journal of Cancer.

[33]  T. Hoshuyama,et al.  Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis , 2007, The Lancet.

[34]  Alessandro Marinaccio,et al.  Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age‐period‐cohort models , 2005, International journal of cancer.

[35]  A. Burdorf,et al.  Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands , 2005, International journal of cancer.

[36]  L. Richiardi,et al.  Population Attributable Risk for Occupational Gancer in Italy , 2005, International journal of occupational and environmental health.

[37]  T. Kauppinen,et al.  Occupational Exposures to Carcinogens in Italy: An Update of CAREX Database , 2005, International journal of occupational and environmental health.

[38]  Ken Takahashi,et al.  A Cross-country Comparative Overview of the Asbestos Situation in Ten Asian Countries , 2003, International journal of occupational and environmental health.

[39]  C. la Vecchia,et al.  An age, period and cohort analysis of pleural cancer mortality in Europe. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[40]  F Levi,et al.  The European mesothelioma epidemic , 1999, British Journal of Cancer.

[41]  J. Peto,et al.  Continuing increase in mesothelioma mortality in Britain , 1995, The Lancet.

[42]  T. Dragani Libri Ricevuti: Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .